, Tracking Stock Market Picks
Enter Symbol:
Dusa Pharmaceuticals, Inc. (DUSA) [hlAlert]

Mkt Outperform
up 577.96 %

Dusa Pharmaceuticals, Inc. (DUSA) rated Mkt Outperform with price target $6 by Rodman & Renshaw

Posted on: Tuesday,  Oct 7, 2008  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) on 10/07/2008, when the stock price was $1.18.
Since then, Dusa Pharmaceuticals, Inc. has gained 577.97% as of 12/20/2013's recent price of $8.00.
If you would have followed this Rodman & Renshaw's recommendation on DUSA, you would have gained 577.96% of your investment in 1900 days.

DUSA Pharmaceuticals, Inc. is a pharmaceutical company developing drugs in combination with light devices to treat or detect a variety of conditions in processes known as photodynamic therapy or photodetection. They are engaged primarily in the research and development of our first drug, the Levulan brand of aminolevulinic acid HCl with light, for use in a broad range of medical conditions.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2008 8:25 AM Buy
1.18 6.00
as of 12/24/2008
1 Week down  -15.38 %
1 Month down  -18.51 %
3 Months up  4.76 %
1 YTD up  4.76 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy